硒蛋白P在急性心肌梗死合并心源性休克中的变化
该研究为IABP-SHOCK II随机试验的预设生物标志物亚组,纳入147例急性心肌梗死合并心源性休克患者,于随机化后第1天和第3天检测硒蛋白P(SelP)水平,并与健康对照比较、分析其与C反应蛋白(CRP)的关联。结果显示患者SelP水平较对照显著升高(第1天为对照的2.7倍,第3天为5.7倍,均P<0.001);第3天SelP高于第75百分位者30天死亡率显著更高(26% vs. 46%,P=0.045);SelP与CRP在第1天(R=0.762,P<0.0001)和第3天(R=0.777,P<0.0001)均显著相关。作者认为SelP升高与炎症过程相关,未来研究应聚焦于SelP谱的特征刻画及受SelP影响的病理机制。
要点
- 在147例急性心肌梗死合并心源性休克患者中,SelP水平较健康对照显著升高:第1天为对照的2.7倍,第3天为对照的5.7倍,均P<0.001。
- 随机化后第3天SelP水平高于第75百分位者30天死亡率显著更高(26% vs. 46%,P=0.045)。
- SelP与CRP在第1天(R=0.762,P<0.0001)和第3天(R=0.777,P<0.0001)均呈显著正相关,提示与炎症过程相关。
- 该分析为IABP-SHOCK II试验的预设生物标志物亚组,样本量147例,SelP检测时间为随机化后第1天和第3天。
- 作者认为未来研究应聚焦于急性心肌梗死后SelP谱的特征刻画及受SelP影响的病理机制。
适用人群与场景
- 急性心肌梗死合并心源性休克患者,来自IABP-SHOCK II随机试验的预设生物标志物亚组,共147例。
- 对照为健康人群。
- 检测时间点为随机化后第1天和第3天。
研究设计与关键结果
- 研究类型:随机试验IABP-SHOCK II的预设生物标志物亚组分析;147例急性心肌梗死合并心源性休克患者,随机分为使用或不使用主动脉内球囊反搏(IABP)治疗。
- 与健康对照相比,梗死相关心源性休克患者SelP水平显著升高:第1天为对照的2.7倍,第3天为对照的5.7倍,均P<0.001。
- 随机化后第3天SelP水平高于第75百分位的患者30天死亡率显著更高(26% vs. 46%,P=0.045)。
- SelP与CRP显著相关:第1天R=0.762(P<0.0001),第3天R=0.777(P<0.0001)。
证据类型、等级与局限
- 证据类型:随机对照试验(IABP-SHOCK II)的预设生物标志物亚组分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐;作者认为未来研究应聚焦于急性心肌梗死后SelP谱的特征刻画及受SelP影响的病理机制的识别。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Reperfusion strategies in acute myocardial infarction (AMI) may result in ischemia reperfusion injury characterized by increased oxidative stress, inflammation, and ultimately death of myocardial tissue which may be of particular importance in infarct-related cardiogenic shock (CS). Many anti-oxidative and immune regulatory processes depend on selenium which in large proportions is bound to circulating selenoprotein P (SelP). Individual SelP patterns may therefore be associated with inflammatory response and possibly mortality in patients with CS post AMI.
METHODS: In the randomized Intra-Aortic Balloon Pump in cardiogenic Shock II (IABP-SHOCK II)-trial, 600 patients with CS complicating AMI were assigned to therapy with or without IABP. In a predefined biomarker substudy of 147 patients, we analyzed SelP levels 1 and 3 days following randomization. Samples were compared with healthy controls and associations with the unspecific inflammatory marker C-reactive protein (CRP) were analyzed.
RESULTS: Compared with controls SelP levels in patients with infarct-related CS were markedly higher (2.7-fold at day 1 and 5.7-fold at day 3 following AMI, all P < 0.001). Thirty-day mortality was significantly higher in patients with SelP levels above the 75th percentile at day 3 following AMI (26% vs. 46%, P = 0.045). SelP was significantly proportionally correlated with CRP 1 (R = 0.762, P < 0.0001) and 3 days (R = 0.777 P < 0.0001) following AMI.
CONCLUSION: SelP levels are significantly increased post AMI with CS. Higher SelP levels are associated with increased CRP levels indicative for inflammatory processes. Future studies should focus on the characterization of SelP profiles following AMI and the identification of pathomechanisms affected by SelP.
参考来源
- Büttner P, Obradovic D, Wunderlich S, et al. Selenoprotein P in Myocardial Infarction With Cardiogenic Shock. Shock. 2020. PMID: 30889044. doi:10.1097/SHK.0000000000001342
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。